Uncategorized

J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal – Reuters

Posted on Author Tim Hodges Comments Off on J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal – Reuters
  1. J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal  Reuters
  2. J&J strikes $14.6 billion deal for Intra-Cellular Therapies  Axios
  3. Johnson & Johnson in $14.6 Billion Deal to Buy Biotech Intra-Cellular  Barron’s
  4. J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion  CNBC
  5. Johnson & Johnson in talks to acquire Intra-Cellular Therapies  Yahoo Finance